“A randomized placebo controlled clinical trial using Homoeopathy as an adjuvant to standard care in the management of COVID-19” [Adv. Integr. Med. 12 (2025) 100502] https://doi.org/10.1016/j.aimed.2025.100502
Advances in Integrative Medicine · 2026-09 · 13 (3) · 100696
DOI: 10.1016/j.aimed.2026.100696 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Integrative Medicine, 2026-09. Verfasst von Susan Arentz.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Arentz, S. (2026). “A randomized placebo controlled clinical trial using Homoeopathy as an adjuvant to standard care in the management of COVID-19” [Adv. Integr. Med. 12 (2025) 100502] https://doi.org/10.1016/j.aimed.2025.100502. Advances in Integrative Medicine, 13(3), 100696. https://doi.org/10.1016/j.aimed.2026.100696
Vancouver
Arentz S. “A randomized placebo controlled clinical trial using Homoeopathy as an adjuvant to standard care in the management of COVID-19” [Adv. Integr. Med. 12 (2025) 100502] https://doi.org/10.1016/j.aimed.2025.100502. Advances in Integrative Medicine. 2026;13(3):100696. doi:10.1016/j.aimed.2026.100696
BibTeX
@article{Arentz2026,
author = {Arentz, Susan},
title = {“A randomized placebo controlled clinical trial using Homoeopathy as an adjuvant to standard care in the management of COVID-19” [Adv. Integr. Med. 12 (2025) 100502] https://doi.org/10.1016/j.aimed.2025.100502},
journal = {Advances in Integrative Medicine},
year = {2026},
volume = {13},
number = {3},
pages = {100696},
doi = {10.1016/j.aimed.2026.100696}
}
EUVIMED